Cyanotech Corporation, a leader in microalgae-based nutrition and health dietary supplements, reported its financial results for the fourth quarter and fiscal year 2025, ended March 31, 2025. For fiscal year 2025, the company achieved net sales of $24.215 million, marking a 5.0% increase from $23.071 million in fiscal 2024. The gross profit for the year was $6.876 million, with a gross profit margin of 28.4%, compared to a gross profit of $5.945 million and a margin of 25.8% in the previous fiscal year. The operating loss was reduced to $2.508 million from $4.592 million. For the fourth quarter of fiscal 2025, Cyanotech reported net sales of $6.3 million, up 5.5% from $5.97 million in the same quarter of fiscal 2024. The gross profit for the quarter was $1.742 million with a margin of 27.7%, improving from $675,000 and an 11.3% margin in the fourth quarter of fiscal 2024. The company saw a significant reduction in its operating loss for the quarter, which was $442,000 compared to $1.903 million in the prior year. Cyanotech's net loss for fiscal 2025 was $3.203 million, an improvement from a net loss of $5.267 million in fiscal 2024. In the fourth quarter, the net loss was $627,000, down from $2.081 million in the same period the previous year. Matthew K. Custer, President and CEO, noted that fiscal 2025 was a year of meaningful progress, highlighting a revenue growth of 5%, an improvement in gross margin by nearly 3 points, and a reduction in operating loss by almost 45%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyanotech Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250620392710) on June 20, 2025, and is solely responsible for the information contained therein.
Comments